BioCentury

1:44 AM GMT, Sep 12, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Regorafenib receives Priority Review in Japan for colorectal cancer

Bayer AG (Xetra:BAYN) said the Japanese Ministry of Health, Labor and Welfare (MHLW) granted Priority

Read the full 152 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.